Alpha Cognition Inc. Reports First Quarter 2026 Financial Results and Provides Operational Update

Alpha Cognition Inc. (ACOG: NASDAQ) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today reported ...

Immune protein emerges as possible target to slow Parkinson's progression

Monoclonal antibodies can block a key immune-related protein that drives the spread of brain cell damage in Parkinson's ...
Neuroscience News

Slowing Parkinson’s by Blocking a Key Protein

Researchers identify GPNMB as a driver of Parkinson’s disease spread and demonstrate that monoclonal antibodies can block its activity to slow neurodegeneration.
eLife

Cross-modal interaction of human alpha activity does not reflect inhibition of early sensory processing in a frequency-tagging study using EEG and MEG

Early visual alpha oscillations correlate on a trial-by-trial basis with steady-state responses at later stages of the processing stream, implying a role in signal enhancement and interareal ...

Rocket Report: Alpha Block 2 coming this summer; Falcon sets booster landing mark

New record set for safe booster landings. On Tuesday, SpaceX launched another routine Falcon 9 mission from Vandenberg Space ...